| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS-CHARACTERIZATION SERIES |
a Department of Genetics, Silberman Institute of Life Sciences, The Hebrew University, Jerusalem, Israel;
b Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;
c The Lautenberg Center for General and Tumor Immunology, Hadassah Medical School, The Hebrew University, Jerusalem, Israel
Key Words. Human embryonic stem cells • Peripheral blood mononuclear cells • Embryoid bodies • Cytotoxic T lymphocytes
Correspondence: Micha Drukker, Ph.D., Department of Genetics, Silberman Institute of Life Sciences, The Hebrew University, 91904 Jerusalem, Israel. Telephone: 972-2-6585183; Fax: 972-2-6584972; e-mail: dmicha{at}mail.ls.huji.ac.il
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases. A crucial step toward their successful clinical application is to examine the immune response that might be launched against them after transplantation. We used two experimental platforms to examine the in vivo leukocyte response toward hESCs. First, immunocompetent and immunodeficient mouse strains were used to identify T cells as the major component that causes xenorejection of hESCs. Second, mice that were conditioned to carry peripheral blood leukocytes from human origin were used to test the human leukocyte alloresponse toward undifferentiated and differentiated hESCs. Using this model, we have detected only a minute immune response toward undifferentiated as well as differentiated hESCs over the course of 1 month, although control adult grafts were repeatedly infiltrated with lymphocytes and destroyed. Our data show that the cells evade immune destruction due to a low immunostimulatory potential. Nevertheless, a human cytotoxic T lymphocyte clone that was specifically prepared to recognize two hESC lines could lyse the cells after major histocompatibility complex class I (MHC-I) induction. Although MHC-I levels in hESCs are sufficient for rejection by cytotoxic T cells, our data suggest that the immunostimulatory capacity of the cells is very low. Thus, immunosuppressive regimens for hESC-based therapeutics could be highly reduced compared with conventional organ transplantation because direct allorejection processes of hESCs and their derivatives are considerably weaker.
This article has been cited by other articles:
|
|
 |
|
  R.-J. Swijnenburg, S. Schrepfer, J. A. Govaert, F. Cao, K. Ransohoff, A. Y. Sheikh, M. Haddad, A. J. Connolly, M. M. Davis, R. C. Robbins, et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts PNAS, September 2, 2008; 105(35): 12991 - 12996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Siepe, P. Akhyari, A. Lichtenberg, C. Schlensak, and F. Beyersdorf Stem cells used for cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 242 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Wu, A. S. Boyd, and K. J. Wood Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack Stem Cells, August 1, 2008; 26(8): 1939 - 1950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Grinnemo, R. Genead, M. Kumagai-Braesch, A. Andersson, C. Danielsson, A. Mansson-Broberg, G. Dellgren, A.-M. Stromberg, H. Ekberg, O. Hovatta, et al. Costimulation Blockade Induces Tolerance to HESC Transplanted to the Testis and Induces Regulatory T-Cells to HESC Transplanted into the Heart Stem Cells, July 1, 2008; 26(7): 1850 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, Y. Suzuki, M. Huang, F. Cao, X. Xie, A. J. Connolly, P. C. Yang, and J. C. Wu Comparison of Reporter Gene and Iron Particle Labeling for Tracking Fate of Human Embryonic Stem Cells and Differentiated Endothelial Cells in Living Subjects Stem Cells, April 1, 2008; 26(4): 864 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-M. Chan, S. Bonde, H. Klump, and N. Zavazava Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells Blood, March 15, 2008; 111(6): 2953 - 2961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Aberdam, E. Barak, M. Rouleau, S. de LaForest, S. Berrih-Aknin, D. M. Suter, K.-H. Krause, M. Amit, J. Itskovitz-Eldor, and D. Aberdam A Pure Population of Ectodermal Cells Derived from Human Embryonic Stem Cells Stem Cells, February 1, 2008; 26(2): 440 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Robertson, F. A. Brook, R. L. Gardner, S. P. Cobbold, H. Waldmann, and P. J. Fairchild Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance PNAS, December 26, 2007; 104(52): 20920 - 20925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Cho, S.-H. Moon, S.-H. Lee, S.-W. Kang, J. Kim, J. M. Lim, H.-S. Kim, B.-S. Kim, and H. M. Chung Improvement of Postnatal Neovascularization by Human Embryonic Stem Cell Derived Endothelial-Like Cell Transplantation in a Mouse Model of Hindlimb Ischemia Circulation, November 20, 2007; 116(21): 2409 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Condorelli and D. Catalucci Human Stem Cells for Heart Failure Treatment: Ready for Prime Time? J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1894 - 1895. [Full Text] [PDF]
|
|
|
|
|
|
B. Coleman, M. G. de Silva, and R. K. Shepherd Concise Review: The Potential of Stem Cells for Auditory Neuron Generation and Replacement Stem Cells, November 1, 2007; 25(11): 2685 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Brunlid, J. Pruszak, B. Holmes, O. Isacson, and K.-C. Sonntag Immature and Neurally Differentiated Mouse Embryonic Stem Cells Do Not Express a Functional Fas/Fas Ligand System Stem Cells, October 1, 2007; 25(10): 2551 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Blum and N. Benvenisty Clonal Analysis of Human Embryonic Stem Cell Differentiation into Teratomas Stem Cells, August 1, 2007; 25(8): 1924 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Levenberg, J. Zoldan, Y. Basevitch, and R. Langer Endothelial potential of human embryonic stem cells Blood, August 1, 2007; 110(3): 806 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Nakajima, K. Tokunaga, and N. Nakatsuji Human Leukocyte Antigen Matching Estimations in a Hypothetical Bank of Human Embryonic Stem Cell Lines in the Japanese Population for Use in Cell Transplantation Therapy Stem Cells, April 1, 2007; 25(4): 983 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Abdullah, T. Saric, H. Kashkar, N. Baschuk, B. Yazdanpanah, B. K. Fleischmann, J. Hescheler, M. Kronke, and O. Utermohlen Serpin-6 Expression Protects Embryonic Stem Cells from Lysis by Antigen-Specific CTL J. Immunol., March 15, 2007; 178(6): 3390 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-J. Chang, M.-L. Yen, Y.-C. Chen, C.-C. Chien, H.-I. Huang, C.-H. Bai, and B. L. Yen Placenta-Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-{gamma} Stem Cells, November 1, 2006; 24(11): 2466 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ellerstrom, R. Strehl, K. Moya, K. Andersson, C. Bergh, K. Lundin, J. Hyllner, and H. Semb Derivation of a Xeno-Free Human Embryonic Stem Cell Line Stem Cells, October 1, 2006; 24(10): 2170 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bonde and N. Zavazava Immunogenicity and Engraftment of Mouse Embryonic Stem Cells in Allogeneic Recipients Stem Cells, October 1, 2006; 24(10): 2192 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Rao One Successful Series Begets Another Stem Cells, October 1, 2006; 24(10): 2160 - 2161. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Caspi and L. Gepstein Stem cells for myocardial repair Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E43 - E54. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
